Vanderbilt Heart and Vascular Institute (VHVI) reached a significant milestone recently with the 100th implantation of the miniaturized HeartWare HVAD Pump, a left ventricular assist device (LVAD) that supports the heart.

The potential for long-range signaling factors – such as those identified in the current study – to regulate stem cell behaviors has implications in tumor progression and metastasis.

Armed with a validated and orchestrated plan, Vanderbilt University Medical Center is prepared to safely and effectively treat patients with the bloodborne disease Ebola, should the need arise.

The Commodore Award, Vanderbilt’s highest staff honor, was presented to two staff members during the Service Awards Celebration Oct. 1 in Langford Auditorium.

For years, scientists have known that regular aspirin use may reduce the risk of cancer.

If you’re a native of rural Mozambique who contracts HIV and becomes symptomatic, before seeking clinical testing and treatment, you’ll likely consult a traditional healer.

A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223.